当前位置: X-MOL 学术React. Chem. Eng. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A multi-step continuous flow synthesis of the cystic fibrosis medicine ivacaftor†
Reaction Chemistry & Engineering ( IF 3.9 ) Pub Date : 2018-05-16 00:00:00 , DOI: 10.1039/c8re00025e
N. Vasudevan 1, 2, 3, 4 , Mrityunjay K. Sharma 2, 3, 4, 5 , D. Srinivasa Reddy 1, 2, 3, 4 , Amol A. Kulkarni 2, 3, 4, 5
Affiliation  

A continuous flow ozonolysis method combined with a multi-step flow sequence is developed for the synthesis of the drug ivacaftor for the first time. Safe ozonolysis, a continuous flow quadruple reaction to construct a quinolone scaffold, and inline extraction followed by continuous phase separation are the key features of the present work. The feasibility of using a continuous mixed flow reactor, commonly referred to as a continuous stirred tank reactor (CSTR), is also investigated for the relatively slow reaction step. The current integrated multi-step flow synthesis can produce 7.2 g of the drug ivacaftor per day on a laboratory scale, which is sufficient to treat 50 patients per day. The present route can also be used as a general route for the synthesis of other related drugs such as quinolone antibiotics.

中文翻译:

囊性纤维化药物依伐卡托的多步连续流合成

首次开发了一种连续流臭氧分解方法与多步流序相结合的方法,用于合成药物依维卡托。安全的臭氧分解,连续流动的四重反应以构建喹诺酮支架,在线提取后进行连续相分离是本研究的关键特征。对于相对较慢的反应步骤,也研究了使用连续混合流反应器(通常称为连续搅拌釜反应器(CSTR))的可行性。当前的集成多步流合成每天可在实验室规模上生产7.2 g的药物依伐卡托,每天足以治疗50名患者。本途径也可以用作合成其他相关药物如喹诺酮类抗生素的一般途径。
更新日期:2018-05-16
down
wechat
bug